|
Volumn 269, Issue 1, 2013, Pages 1-3
|
Science to practice: Can stem cells be labeled inside the body instead of outside?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALCIAN BLUE;
FERRIC FERROCYANIDE;
FERUCARBOTRAN;
FERUMOXYTOL;
HEPARIN;
IRON;
PROTAMINE SULFATE;
SUPERPARAMAGNETIC IRON OXIDE;
ARTICLE;
BIOLOGICAL MONITORING;
BONE DEFECT;
CARTILAGE CELL;
CELL CULTURE;
CELL ISOLATION;
CELL LABELING;
CELLULAR DISTRIBUTION;
CEREBROVASCULAR ACCIDENT;
CHONDROGENESIS;
CHONDROPATHY;
CLINICAL PRACTICE;
DRUG TOXICITY;
ENDOSOME;
ENGRAFTMENT;
EX VIVO STUDY;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HEMATOPOIETIC STEM CELL;
HISTOPATHOLOGY;
HUMAN;
IN VIVO STUDY;
INSULIN DEPENDENT DIABETES MELLITUS;
IRON THERAPY;
LYSOSOME;
MESENCHYMAL STEM CELL;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MULTIPLE SCLEROSIS;
NON INVASIVE PROCEDURE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OFF LABEL DRUG USE;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
STEM CELL;
ANIMALS;
CELL TRACKING;
FERUMOXYTOL;
MAGNETIC RESONANCE IMAGING;
STEM CELL TRANSPLANTATION;
STEM CELLS;
|
EID: 84884687455
PISSN: 00338419
EISSN: 15271315
Source Type: Journal
DOI: 10.1148/radiol.13131753 Document Type: Article |
Times cited : (13)
|
References (9)
|